Menu

• Ask a Health Expert about PNEUMOCOCCAL BACTERAEMIA
• Post Your Side Effect related to PNEUMOCOCCAL BACTERAEMIA
• PNEUMOCOCCAL BACTERAEMIA and FDA Warnings
• PNEUMOCOCCAL BACTERAEMIA in Patients Wiki
• Report PNEUMOCOCCAL BACTERAEMIA in Drug Side Effect Survey

PNEUMOCOCCAL BACTERAEMIA side effect

What is PNEUMOCOCCAL BACTERAEMIA ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Ibandronic Side Effects Report #5697829-9
Consumer or non-health professional from UNITED KINGDOM reported IBANDRONIC ACID problem on Mar 31, 2008. Female patient, weighting 119.9 lb, was diagnosed with osteoporosis and was treated with IBANDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: pneumococcal bacteraemia, . IBANDRONIC ACID dosage: unknown. During the same period patient was treated with GLUCOSAMINE, EMULSIFYING OINTMENT, EMULSIFYING OINTMENT, EMULSIFYING OINTMENT, CALCICHEW D, CALCICHEW D, FOSAMAX. Patient was hospitalized. Patient recovered.

Advil Side Effects Report #5268829-8
ADVIL problem was reported by a Health Professional from FRANCE on Mar 14, 2007. Female patient, weighting 40.79 lb, was diagnosed with influenza and was treated with ADVIL. After drug was administered, patient experienced the following problems/side effects: pneumococcal bacteraemia, pneumonia pneumococcal, . ADVIL dosage: 30 MG/KG TOTAL DAILY. During the same period patient was treated with TOPLEXIL, ACETAMINOPHEN. Patient was hospitalized. Patient recovered.

Enbrel Side Effects Report #5632943-5
Health Professional from BELGIUM reported ENBREL problem on Feb 11, 2008. Female patient, 57 years of age, was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: pericardial effusion, pericarditis infective, pneumococcal bacteraemia, renal failure acute, tachycardia, . ENBREL dosage: unknown. Patient was hospitalized. Patient recovered.

Kaletra Side Effects Report #5510801-4
KALETRA problem was reported by a Consumer or non-health professional from PERU on Dec 29, 2005. Female patient, 32 years of age, weighting 105.8 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cryptococcosis, opportunistic infection, pneumococcal bacteraemia, . KALETRA dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE. Patient recovered.


Kaletra Side Effects Report #5531133-4
Consumer or non-health professional from PERU reported KALETRA problem on Nov 22, 2007. Female patient, 32 years of age, weighting 105.8 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: cryptococcosis, opportunistic infection, pneumococcal bacteraemia, . KALETRA dosage: unknown. During the same period patient was treated with STAVUDINE, LAMIVUDINE. Patient was hospitalized. Patient recovered.

Kaletra Side Effects Report #5344736-7
KALETRA problem was reported by a Physician from CHILE on May 25, 2007. Male patient, weighting 130.1 lb, was diagnosed with hiv infection and was treated with KALETRA. After drug was administered, patient experienced the following problems/side effects: anorectal infection, pneumococcal bacteraemia, pyrexia, rectal discharge, sepsis, . KALETRA dosage: unknown. During the same period patient was treated with LAMIVUDINE, ZIDOVUDINE. Patient was hospitalized. Patient recovered.

Champix Side Effects Report #5290920-0
Health Professional from UNITED KINGDOM reported CHAMPIX problem on Mar 28, 2007. Female patient, 48 years of age, weighting 154.3 lb, was diagnosed with ex-smoker and was treated with CHAMPIX. After drug was administered, patient experienced the following problems/side effects: adenoma benign, gastrointestinal obstruction, pneumococcal bacteraemia, . CHAMPIX dosage: unknown. Patient was hospitalized. Patient recovered.